top of page

$50 Million Revenue Nationwide Specialty Pharmacy

Listing Code:



Not Disclosed



Asking Price:




Company Overview

American HealthCare Capital is pleased to exclusively represent a nationwide specialty pharmacy for sale. Based on the east coast, this URAC and ACHC accredited pharmacy is licensed in all states except California. They focus on treating a wide range of conditions, including Rheumatology, Dermatology, Allergies, Gastroenterology, Nephrology, and much more.

Financial Overview

Over the past year, the East Coast pharmacy has dispensed an average of 1,400 scripts per month, and they are quickly growing. Gross revenues were $36.9 million in 2022 with an adjusted EBITDA of $767,229. In 2023, they expect to end the year at around $50 million in gross revenues with an adjusted EBITDA of $2.5 million. In 2024, the company is anticipating continued exponential growth. With monthly gross revenues currently trending towards $6 million and growing, plus a new limited distribution drug that should generate around $10 million in gross revenues, they expect to reach $80 – $100 million in 2024.

Staff Overview

The staff is expected to stay on under new ownership, and the current owners will assist during a transitional period.

Asking Price

The sellers of this nationwide specialty pharmacy will consider all competitive offers.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.


2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:


Listing Title:

$50 Million Revenue Nationwide Specialty Pharmacy

Heading 4

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi


American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings.

Thanks for submitting!

bottom of page